CRH (CRH) Financial History
Review CRH annual and quarterly financial results, key ratios, insider transactions and SEC filing history in one chronological view. Data available from FY2018 through FY2025.
Financials
8 fiscal years, FY2018 to FY2025
Insider trades
132 trades
Risk factor changes
23 changes in the latest 10-K
Filings
Annual and quarterly reports
Compare
Side by side with another company
CRH Financial Statements
History since FY2018. Annual, in US dollars. Source: 10-K XBRL data.
CRH Revenue and Growth
Compare reported revenue and year-over-year revenue growth across available fiscal years.
CRH Income Statements
Review revenue, gross profit, operating income, net income and earnings per share.
CRH Balance Sheets
Review reported debt and book-value-based ratios where company data is available.
CRH Cash Flow Statements
Compare reported free cash flow across the available fiscal history.
CRH Financial Ratios
Compare net margin, price-to-earnings and price-to-book ratios by fiscal year.
| Fiscal year | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ••••• | ••••• | ••••• | $29.2B | $32.7B | $34.9B | $35.6B | $37.4B |
| Revenue growth | ••••• | ••••• | ••••• | — | +12.0% | +6.8% | +1.8% | +5.3% |
| Gross profit | ••••• | ••••• | ••••• | $9.8B | $10.8B | $12.0B | $12.7B | $13.5B |
| Operating income | ••••• | ••••• | ••••• | $3.3B | $3.8B | $4.2B | $4.9B | $5.4B |
| Net income | ••••• | ••••• | ••••• | $2.6B | $3.9B | $3.2B | $3.5B | $3.8B |
| Debt | ••••• | ••••• | ••••• | — | $9.7B | $11.8B | $14.2B | $18.2B |
| Free cash flow | ••••• | ••••• | ••••• | $2.4B | $2.3B | $3.2B | $2.4B | $2.9B |
| Net margin | ••••• | ••••• | ••••• | 9.0% | 11.8% | 9.1% | 9.8% | 10.0% |
| EPS (diluted) | ••••• | ••••• | ••••• | $3.32 | $5.11 | $4.33 | $5.02 | $5.51 |
| P/E ratio | ••••• | ••••• | ••••• | 15.9× | 7.8× | 16.2× | 18.4× | 22.7× |
| P/B ratio | ••••• | ••••• | ••••• | — | 1.4× | 2.5× | 3.1× | 3.7× |
Daily closing prices, aggregated by calendar year.
| Year | 2004 🔒 | 2005 🔒 | 2006 🔒 | 2007 🔒 | 2008 🔒 | 2009 🔒 | 2010 🔒 | 2011 🔒 | 2012 🔒 | 2013 🔒 | 2014 🔒 | 2015 🔒 | 2016 🔒 | 2017 🔒 | 2018 🔒 | 2019 🔒 | 2020 🔒 | 2021 🔒 | 2022 | 2023 | 2024 | 2025 | 2026 (YTD) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Open | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $52.93 | $41.38 | $68.36 | $93.14 | $125.43 |
| Close | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $39.77 | $69.99 | $92.56 | $124.81 | $95.44 |
| High | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $54.53 | $69.99 | $104.22 | $129.26 | $131.56 |
| Low | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $31.23 | $40.80 | $65.86 | $76.81 | $78.62 |
| Annual return | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | -24.7% | +76.0% | +32.2% | +34.8% | -23.5% |
CRH Insider Transactions
From Form 4 filings. Showing the latest 5 of 132 trades.
| Traded | Filed | Insider | Type | Shares | Value | % of holdings |
|---|---|---|---|---|---|---|
| 2026-11-03 | 2026-11-05 | Siobhan Talbot Director | Bought | 2,000 | $189K at ~$94.63 | +24% |
| 2026-05-15 | 2026-05-18 | Padraig ORiordain See Remarks | Sold | 1,492 | $156K at ~$104 | — |
| 2026-05-13 | 2026-05-15 | Badar Khan Director | Option exercise (10 trades) | 19,900 | — | — |
| 2026-05-13 | 2026-05-15 | Badar Khan Director | Grant or award (5 trades) | 7,780 | — | — |
| 2026-05-13 | 2026-05-15 | Christina Campbell Verchere Director | Option exercise (10 trades) | 19,900 | — | — |
CRH Risk Factor Changes
Latest 10-K compared with the year before. 23 changes found.
6** Represents a non-GAAP measure.
Counterparty risks
Interest rate and leverage risks
In addition, the Company regularly engages in acquisition activity as part of its active portfolio management.
Major Business Interruption
Enabling Business Technology
Any failure to maintain strong customer relationships could result in an inability to respond to changing consumer preferences and approaches to construction.
Early-Stage Business/Technology Investment
The failure to plan adequately for current and future extraction and utilization or to ensure ongoing compliance with requirements of issuing authorities could lead to operational disruptions and negatively affect our…
The occurrence or recurrence of disruptive/dangerous pandemics could materially endanger our workers and/or contractors.
In addition, CRH may also be negatively impacted by fluctuations in the price of fuel and principal energy-related raw materials, which accounted for approximately 10% of Total revenues in 2025, consistent with 10% in…
Risks Related to Our Industry and Our Business
This Form 10-K also contains forward-looking statements that involve risks and uncertainties.
In addition to the other information contained in this Form 10-K, you should carefully consider the following risk factors before investing in our Ordinary Shares.
Following the transition to the NYSE, CRH has been added to the MSCI USA Equity Index, the S&P TMI Index and the Russell 1000 Equity Index.
On September 25, 2023, CRH relocated the primary listing of its ordinary shares from the LSE to the NYSE.
CRH faces risks associated with the relocation of our primary listing.
Payment of Dividends/Share Repurchase Program
Taxation Charge and Balance Sheet Provisioning
Early Stage Business/Technology Investment
Strategic Mineral Reserves and Permitting
Industry Cyclicality and Economic Conditions
Risks Related To Our Industry And Our Business
CRH SEC Filings
Latest annual and quarterly reports, current reports, proxy statements and ownership filings.
| Form | Filed | Description | Document |
|---|---|---|---|
| Current report (8-K) | 2026-11-04 | Other news | View document |
| Registration or offering | 2026-11-04 | Securities offering | View document |
| Quarterly report (10-Q) | 2026-10-29 | Quarter ended Sep 30, 2026 | View document |
| Current report (8-K) | 2026-10-29 | Quarterly results | View document |
| Current report (8-K) | 2026-10-23 | Company update | View document |
CRH financial metrics by year
CRH in the S&P 500 rankings
- #99 by revenue as of FY2025
- #81 by operating income as of FY2025
S&P 500 is a trademark of S&P Dow Jones Indices LLC. StockYears is not affiliated with or endorsed by S&P Dow Jones Indices.